| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 28.69B | 27.09B | 26.19B | 19.94B | 20.21B |
| Gross Profit | 1.62B | 1.71B | 1.64B | -2.38B | -412.83M |
| EBITDA | 3.83B | 3.48B | 3.43B | -661.49M | 672.58M |
| Net Income | 1.43B | 1.06B | 1.06B | -1.99B | -973.96M |
Balance Sheet | |||||
| Total Assets | 36.94B | 36.57B | 37.23B | 37.04B | 37.40B |
| Cash, Cash Equivalents and Short-Term Investments | 4.15B | 1.93B | 1.48B | 1.30B | 1.56B |
| Total Debt | 1.33B | 2.13B | 2.81B | 2.88B | 1.68B |
| Total Liabilities | 8.69B | 9.50B | 10.88B | 11.79B | 10.20B |
| Stockholders Equity | 28.29B | 27.11B | 26.39B | 25.29B | 27.24B |
Cash Flow | |||||
| Free Cash Flow | 2.78B | 1.42B | 94.06M | -1.85B | -57.79M |
| Operating Cash Flow | 3.46B | 2.71B | 1.12B | -193.45M | 1.00B |
| Investing Cash Flow | -202.56M | -1.28B | -822.84M | -1.43B | -926.11M |
| Financing Cash Flow | -1.05B | -982.24M | -110.70M | 1.42B | -62.13M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | HK$203.05B | 13.19 | 9.59% | 4.35% | -0.99% | 80.58% | |
74 Outperform | HK$23.15B | 9.75 | 4.72% | 3.48% | ― | ― | |
72 Outperform | HK$5.72B | 13.83 | 1.61% | 7.48% | 2.87% | -35.74% | |
71 Outperform | HK$1.10B | 4.31 | 8.94% | 1.38% | 15.60% | 469.61% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | HK$114.20M | -33.99 | 2.17% | 8.79% | 6.83% | -91.46% | |
51 Neutral | HK$2.36B | 47.75 | 7.67% | 0.87% | -14.80% | 11.92% |